Adenosine A_2A receptor blockade prevents cisplatin-induced impairments in neurogenesis and cognitive function.

ABSTRACT: Chemotherapy-induced cognitive impairment (CICI) has emerged as a significant medical problem without therapeutic options. Using the platinum-based chemotherapy cisplatin to model CICI, we revealed robust elevations in the adenosine A_2A receptor (A_2AR) and its downstream effectors, cAMP and CREB, by cisplatin in the adult mouse hippocampus, a critical brain structure for learning and memory. Notably, A_2AR inhibition by the Food and Drug Administration-approved A_2AR antagonist KW-6002 prevented cisplatin-induced impairments in neural progenitor proliferation and dendrite morphogenesis of adult-born neurons, while improving memory and anxiety-like behavior, without affecting tumor growth or cisplatin's antitumor activity. Collectively, our study id

SUBMITTER: Oliveros A 

PROVIDER: S-EPMC9282426 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature